MedTrace Logo

Clinical Effects of a Formula With Modified Protein Levels and Fat Blend in Preterm Infants

NCT03055052 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2018-08-03

No results posted yet for this study

Summary

This study evaluates the effects of infant formula with higher protein level and improved fat blend on growth and feeding tolerance in preterm infants. Half of the subjects will receive a standard infant formula, while the other half will receive a infant formula with a higher protein level and improved fat blend.

Conditions

  • Infant, Premature, Nutrition

Interventions

OTHER

Standard formula for preterm infants

Reconstituted in water and given to infants at more than 50% of feedings.

OTHER

Formula with higher protein and new fat blend for preterm infants

Reconstituted in water and given to infants at more than 50% of feedings.

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Leslie Tan · Société des Produits Nestlé (SPN)

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
33 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-03-18
Completion
2018-06-25

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03055052 on ClinicalTrials.gov